Kymera Therapeutics (KYMR) Stock Chart & Stock Price History $30.20 -0.19 (-0.63%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$30.21 +0.01 (+0.03%) As of 03/27/2025 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kymera Therapeutics Stock Price Performance 5 Day Performance-7.19%1 Month Performance-3.67%3 Month Performance-24.71%6 Month Performance-37.97%Year-To-Date Performance-24.93%1 Year Performance-24.88% Receive KYMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address KYMR Stock Chart for Friday, March, 28, 2025 KYMR Chart by TradingViewRemove Ads Kymera Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2025$30.39$30.20-0.63%$30.89$30.00211,978 shs$1.96 billion03/26/2025$31.82$30.39-4.49%$31.83$29.83476,678 shs$1.97 billion03/25/2025$33.70$31.82-5.58%$34.10$31.53511,062 shs$2.07 billion03/24/2025$32.54$33.70+3.56%$35.28$32.88416,570 shs$2.19 billion03/21/2025$33.21$32.54-2.02%$33.90$32.08868,196 shs$2.11 billion03/20/2025$33.87$33.21-1.95%$34.71$32.98608,869 shs$2.16 billion03/19/2025$34.03$33.87-0.47%$34.75$32.75506,379 shs$2.20 billion03/18/2025$34.49$34.03-1.33%$34.41$33.15554,825 shs$2.21 billion03/17/2025$34.37$34.49+0.35%$34.71$33.37374,478 shs$2.24 billion03/14/2025$33.45$34.37+2.75%$34.99$33.61665,875 shs$2.23 billion Get the Latest News and Ratings for KYMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/13/2025$35.10$33.45-4.70%$35.51$33.11694,945 shs$2.17 billion03/12/2025$33.27$35.10+5.50%$35.18$33.24647,091 shs$2.28 billion03/11/2025$33.02$33.27+0.76%$33.83$31.54778,070 shs$2.16 billion03/10/2025$32.89$33.02+0.40%$33.70$32.43755,310 shs$2.14 billion03/07/2025$32.54$32.89+1.08%$33.56$31.75639,628 shs$2.14 billion03/06/2025$31.70$32.54+2.65%$32.69$30.39684,174 shs$2.11 billion03/05/2025$30.68$31.70+3.32%$32.00$29.97606,724 shs$2.05 billion03/04/2025$30.17$30.68+1.69%$30.96$29.07608,129 shs$1.99 billion03/03/2025$31.35$30.17-3.76%$31.66$29.79982,064 shs$1.95 billion02/28/2025$29.98$31.35+4.58%$31.49$29.162.13 million shs$2.03 billion02/27/2025$35.38$29.98-15.27%$35.34$29.221.72 million shs$1.94 billion Related Companies ROIV Stock Chart SRPT Stock Chart RVMD Stock Chart BBIO Stock Chart LNTH Stock Chart TGTX Stock Chart LEGN Stock Chart AXSM Stock Chart TLX Stock Chart BPMC Stock Chart Receive KYMR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kymera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KYMR) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kymera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kymera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KYMR Stock Free KYMR Stock Alerts